Content about Eli Lilly and Company

May 22, 2012
BD introduces syringe with smaller needle for diabetes patients

Medical supply manufacturer BD has released a syringe with a shorter needle designed to reduce discomfort in patients with diabetes who must inject insulin, the company said Tuesday.

May 4, 2012
E-prescribing up by 75% in 2011, Surescripts says

More than one-third of prescriptions were sent electronically in 2011, the country's largest e-prescribing network said.

April 25, 2012
Sun launches generic version of Zyprexa

Sun Pharmaceutical Industries has launched a generic version of a drug used to treat psychiatric disorders, the company said.

April 24, 2012
Dr. Reddy's launches generic version of Zyprexa

Dr. Reddy's Labs has launched a generic version of an Eli Lilly drug used to treat psychiatric disorders, the company said Tuesday.

April 24, 2012
Mylan launches generic schizophrenia, bipolar disorder drug

Mylan has launched a generic drug for treating psychiatric disorders, the company said Tuesday.

April 13, 2012
Lilly chief executive John Lechleiter appointed as PhRMA chairman

The Pharmaceutical Research and Manufacturers of America announced Friday the appointment of Eli Lilly chairman, president and CEO John Lechleiter as PhRMA chairman at its annual meeting.

April 10, 2012
FDA approves Watson diarrhea drug

The Food and Drug Administration has approved a generic version of a drug for diarrhea made by Watson, the company said Tuesday.

April 2, 2012
FDA OKs Levemir for pregnant women

A diabetes treatment made by Novo Nordisk is safe for pregnant women, according to a recent decision by the Food and Drug Administration.

March 13, 2012
Pfizer, Biocon end biosimilar insulin deal

Pfizer and Indian drug maker Biocon have ended a partnership that the companies started in 2010 to develop biosimilar treatments for diabetes, the companies said.

March 8, 2012
Bydureon takes on diabetes

The market for drugs to treat diabetes — especially Type 2 diabetes — has shown quite a bit of activity lately.

March 7, 2012
Diabetes drug from Lilly, BI hits shelves

A new drug for Type 2 diabetes made by Eli Lilly and Boehringer Ingelheim is available in pharmacies, the companies said Wednesday.

February 3, 2012
New diabetes drug launches show primary care market still strong

For all the fears about the patent cliff, at least one disease state seems to be on the up-and-up in terms of new drug development and new products.

February 3, 2012
Survey: Endocrinologists would prescribe Bydureon for 20% of patients

Endocrinologists would prescribe a newly approved weekly treatment for Type 2 diabetes to one-fifth of their patients, a new survey showed.

February 3, 2012
Teva launches generic schizophrenia, bipolar disorder drug

Teva Pharmaceuticals has launched a generic version of a psychiatric drug, the company said Friday.

January 31, 2012
FDA approves Lilly-Boehringer Ingelheim diabetes drug

The Food and Drug Administration has approved a new treatment for Type 2 diabetes made by Eli Lilly and Boehringer Ingelheim, the drug makers said.

January 30, 2012
Actavis partners with Poland's Bioton to develop insulin products

Iceland-based drug maker Actavis and Poland-based Bioton have formed a partnership that they said would "shake up" the diabetes market.

January 30, 2012
FDA approves Bydureon

The Food and Drug Administration has approved a long-acting injected diabetes drug made by Amylin Pharmaceuticals and Alkermes, the two companies said.

January 16, 2012
FDA issues alert about sharing of insulin pens

The Food and Drug Administration's latest message to consumers and healthcare professionals seems like a no-brainer: "Insulin pens are not for sharing."

January 9, 2012
Perrigo buys CanAm Care

Drug maker Perrigo is buying a privately owned distributor of diabetes products, the company said Monday.

December 16, 2011
FDA approves new labeling for ViroPharma's Vancocin

ViroPharma has received approval for updated labeling to its antibiotic drug.

December 14, 2011
FDA advisory committee recommends approval for schizophrenia, bipolar disorder drug

A Food and Drug Administration panel has voted to recommend approval for a psychiatric drug made by Alexza Pharmaceuticals.

December 13, 2011
Report: New Wash. law cuts off patient access to painkillers

A new law in Washington state intended to curb accidental deaths related to opioid painkillers is having some adverse side effects, according to published reports.

December 9, 2011
Lilly expands Spanish-language section of 'Lilly for Better Health' Web portal

Drug maker Eli Lilly has expanded its Spanish-language portal, the company said Friday.

December 8, 2011
Insulin combination treats low blood sugar in diabetes patients, study finds

A combination of two insulins made by Novo Nordisk reduced abnormally low blood sugar in diabetes patients, according to study results presented at a medical conference.

December 1, 2011
Lilly study to determine why many diabetes patients don't reach blood-glucose goals

Many people with Type 2 diabetes have managed to integrate the treatments they must take into their daily lives, but many do not reach their blood-glucose goals after they start insulin therapy.

© 2012 Drug Store News. All Rights Reserved.